Eisai Machinery U.S.A. Inc. Acquires Parenteral Product Line From M.W. Technologies, Inc.

Hackensack, N.J - Eisai Machinery U.S.A. Inc., a pharmaceutical machinery marketing and maintenance subsidiary of Tokyo-based Eisai Co., Ltd., recently announces the acquisition of the parenteral machinery line from M.W. Technologies, Inc. The machines offer a solution for customers to conduct manual and semi-automatic inspection of parenteral - or intravenous - products, which is required by the U.S. Pharmacopeia and enforced by the U.S. Food and Drug Administration. Additionally, the acquisition serves to add manual and semi-automatic inspection machines to Eisai Machinery's existing product line of fully automatic inspection machines.

"Guided by a philosophy that defines our role as a human health care company - to give first thought to patients and their families and increase the benefits that health care provides - Eisai Machinery continues to expand its range of inspection equipment," says Michael de la Montaigne, President, Eisai Machinery U.S.A. Inc. "The acquisition of the manual and semi-automatic parenteral product line will further enhance our capabilities to provide quality service and machines to our customers."

The MIH-1 Free Standing Manual Inspection Station, MIH-dx Portable Manual Inspection Hood and MIH-dxs Semi-Automatic Manual Inspection Hood are ideal for small volume and sensitive product production runs, clinical labs, re-work of rejects from fully automated machines and as a validation tool for operators of this system and other in-line semi-automatic inspection systems. In addition, multiple inspection hoods up to 12 stations with transport conveyors are available for higher production levels.

The VIS-1000 inspection system provides a simple, effective method of inspecting pharmaceutical vials and ampoules. Both empty and filled products can be inspected with ease for a wide range of manufacturing flaws related to container and product integrity.

SOURCE: Eisai Machinery U.S.A. Inc.